Philip A. Berger - Concepedia

Author

Philip A. Berger

Also Known As

Berger, Philip, P A Berger, P BERGER, P Berger, P. A. Berger, P. Berger, P.A. Berger, PHILIP A. BERGER, Philip A Berger, Philip A. Berger

130

Publications

Citations

H-Index

Concepts

All Affiliations

Stanford University Palo Alto Veterans Institute for Research United States Department of Veterans Affairs Stanford Medicine

About

Philip A. Berger is an author at Stanford University specializing in medicine, psychiatry, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	57	3K
2	Social Sciences	24	34	2.1K
3	Health Sciences	6	6	120
4	Endocrinology	5	5	245
5	Allergy	1	1	68

Philip A. Berger

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Auditory event-related potentials in schizophrenia and depression Walton T. Roth, Adolf Pfefferbaum, Andrew Kelly, Psychiatry Research Auditory Event-related PotentialsAuditory ImageryNeuropsychologyPsychiatryPsychotic Disorder	1981	202
Effects of Naloxone on Schizophrenia: Reduction in Hallucinations in a Subpopulation of Subjects Stanley J. Watson, Philip A. Berger, Huda Akil, Science NeuropsychologyPsychoactive DrugPsychiatryPsychotic DisorderAddiction	1978	169
CSF monoamine metabolites in depression and schizophrenia Philip A. Berger, Kym F. Faull, J Kilkowski, American Journal of Psychiatry NeuropsychologyPsychoactive DrugPsychiatrySubcortical Ischemic DepressionProbenecid Technique	1980	163
Choline in tardive dyskinesia and Huntington's disease Kenneth L. Davis, Leo E. Hollister, Jack D. Barchas, Life Sciences Corticobasal DegenerationPathologyDegenerative DiseaseNeurologyTardive Dyskinesia	1976	154
Mood disorders pharmacologic prevention of recurrences David J. Kupfer, Philip A. Berger, J Janeway, American Journal of Psychiatry PsychiatryMedicinePsychotropic MedicationPsychopharmacologyDepression	1985	154
Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders Stephen M. Stahl, Dennis Woo, Ivan N. Mefford, American Journal of Psychiatry Platelet Serotonin ConcentrationsPsychotropic MedicationPsychopharmacologyNeuropsychiatryPharmacotherapy	1983	142
P3 reduction in auditory evoked potentials of schizophrenics Walton T. Roth, Adolf Pfefferbaum, Thomas Horvath, Electroencephalography and Clinical Neurophysiology PsychiatryNeurophysiologyP3 ReductionPsychotic DisorderSchizophrenia	1980	138
Age and the dexamethasone suppression test in depression Keith L. Davis, Belinda Davis, Aleksander A. Mathé, American Journal of Psychiatry PsychopathologyStress HormonePsychiatryMood SymptomPlasma Cortisol Concentrations	1984	120
Speech and voice parameters of depression: A pilot study John Darby, Nina N. Simmons, Philip A. Berger Journal of Communication Disorders Speech AnalysisPsychiatryVoice ParametersMood SymptomDepression	1984	107
Neuroendocrine and neurochemical measurements in depression Keith L. Davis, Leo E. Hollister, Aleksander A. Mathé, American Journal of Psychiatry Neurochemical MeasurementsPsychopathologyHamilton ScoreMental HealthSocial Sciences	1981	107

Page 1